Kevin Koch

Kevin Koch, Ph.D., has served as our President, Chief Executive Officer and a member of our board of directors since 2017. Since 2016, he has also served as a Venture Partner with OrbiMed. Dr. Koch has been active in the life science industry for 20+ years with a focus on drug discovery, translational medicine and clinical development. Most recently, Dr. Koch was the Senior Vice President of Drug Discovery: Chemical and Molecular Therapeutics at Biogen where he managed global drug discovery and biomarker development as well as the immunology and hematology teams. From 1998 to 2013, Dr. Koch served as the President, Chief Scientific Officer, Board member and Co-Founder of Array BioPharma Inc. While there, he built a fully integrated R&D team that oversaw the invention of over 20 clinical development candidates in the multiple therapeutic areas. Prior to Array, Dr. Koch held senior positions at Amgen Inc. and Pfizer Central Research. Dr. Koch received a B.S. in Chemistry and Biochemistry from State University of New York, Stony Brook, and his Ph.D. in Organic Chemistry from University of Rochester.